News / Events

Urosphere/ Urolead and Institut Curie will present their last results at the AACR meeting, Denver: Bladder Cancer: Transforming the Field.


aacr image

Urosphere/ Urolead and Institut Curie will present their last results at the AACR meeting, Denver: Bladder Cancer: Transforming the Field.

Fruit of a long term collaboration, Urosphere and its affiliate Urolead (Toulouse) and Institut Curie (Paris) will present a fully characterized biobank of PDXs from bladder cancers and its relevant use as a drug discovery platform.

The results will be presented in poster session A, on Sunday, May 19th and in plenary session 5, on Monday, May 20th.

Title: Establishment of a panel of patient-derived tumor xenograft models recapitulating molecular heterogeneity and drug response of muscle-invasive bladder tumors.

Isabelle Bernard-Pierrot, Institut Curie, Paris, France, poster board number A24

Title: PDX and genetic mouse models for deciphering signaling pathways in bladder cancer.
François R. Radvanyi, Institut Curie, Paris, France, Plenary Session 5: Models for Discovery

logos aacr denver

Please, do not hesitate to attend these sessions and contact us.

UROLEAD will present its PDX tumor models at the American Association for Cancer Research (AACR) Annual Meeting 2019 in Atlanta.


Authors: Hervé Lang, Claire Béraud, Myriam Lassalle, Véronique Lindner, Eric Potiron, Philippe Lluel and Thierry Massfelder.
Abstract Number: 3138

High specific characterization of patient-derived tumor xenograft models for accelerating drug development in muscle-invasive bladder cancers.

Authors: Hervé Lang, Claire Béraud, Myriam Lassalle, Véronique Lindner, Michel Soulié, Xavier Gamé, Pascal Rischmann, Yves Allory, François Radvanyi, Isabelle Bernard-Pierrot, Philippe Lluel and Thierry Massfelder.
Abstract Number: 3526

AACR annual meeting 2019 in Atlanta



Happy New Year 2018

Urolead and Urosphere wishes you happiness, good health and success for this new year 2018.

Urolead will present a poster at the 33rd annual EAU congress (16-20 March 2018)

"An extensive panel of patient-derived bladder cancer xenografts representing the various molecular subtypes of muscle-invasive bladder cancers (MIBC)".


It will be a pleasure to meet you during the EAU congress. Don't hesitate to contact us.